# Horizon Kinetics Holding Corp: financial statements, quarterly

HKHC · OTC · CIK 88000 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hkhc.md) · [Financials](/companies/hkhc/financials.md) · [Filings](/companies/hkhc/filings.md) · [Insiders](/companies/hkhc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hkhc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [11.8](/filings/0000950170-25-047559.md) | [10.6 d](/filings/0000950170-25-047560.md) | [12.1](/filings/0000950170-25-071619.md) | [11.4](/filings/0000950170-25-107298.md) | [13.1](/filings/0001193125-25-280136.md) | [18.2 d](/filings/0001193125-26-104113.md) | [19.0](/filings/0001193125-26-225482.md) | [18.9](/filings/0001193125-26-349320.md) | [17.9](/filings/0001193125-25-280136.md) | [17.0 d](/filings/0001193125-26-104113.md) | [18.3](/filings/0001193125-26-225482.md) | [19.0](/filings/0001193125-26-349320.md) |
| Cost of revenue | $m | [0.6](/filings/0000950170-23-060223.md) | [0.4 d](/filings/0000950170-24-036394.md) | [0.5](/filings/0000950170-24-055614.md) | [0.4](/filings/0000950170-24-089245.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | [0.4](/filings/0000950170-23-060223.md) | [0.4 d](/filings/0000950170-24-036394.md) | [0.4](/filings/0000950170-24-055614.md) | [0.3](/filings/0000950170-24-089245.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [0.4](/filings/0000950170-25-047559.md) | [0.5 d](/filings/0000950170-25-047560.md) | [0.6](/filings/0000950170-25-071619.md) | [0.5](/filings/0000950170-25-107298.md) | [0.6](/filings/0001193125-25-280136.md) | [0.7 d](/filings/0001193125-26-104113.md) | [1.1](/filings/0001193125-26-225482.md) | [0.2](/filings/0001193125-26-349320.md) | [0.8](/filings/0001193125-25-280136.md) | [0.7 d](/filings/0001193125-26-104113.md) | [0.7](/filings/0001193125-26-225482.md) | [0.7](/filings/0001193125-26-349320.md) |
| Operating income | $m | [0.3](/filings/0000950170-25-047559.md) | [(1.6) d](/filings/0000950170-25-047560.md) | [(0.1)](/filings/0000950170-25-071619.md) | [(0.7)](/filings/0000950170-25-107298.md) | [(0.9)](/filings/0001193125-25-280136.md) | [(14.4) d](/filings/0001193125-26-104113.md) | [1.7](/filings/0001193125-26-225482.md) | [3.7](/filings/0001193125-26-349320.md) | [2.9](/filings/0001193125-25-280136.md) | [2.8 d](/filings/0001193125-26-104113.md) | [(4.3)](/filings/0001193125-26-225482.md) | [3.0](/filings/0001193125-26-349320.md) |
| Interest expense | $m | [0.0](/filings/0000950170-23-060223.md) | [0.0 d](/filings/0000950170-24-036394.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.1](/filings/0000950170-25-047559.md) | [0.6 d](/filings/0000950170-25-047560.md) | [1.2](/filings/0000950170-25-071619.md) | [0.2](/filings/0000950170-25-107298.md) | [69.3](/filings/0001193125-25-280136.md) | [33.6 d](/filings/0001193125-26-104113.md) | [10.4](/filings/0001193125-26-225482.md) | [(3.8)](/filings/0001193125-26-349320.md) | [(10.4)](/filings/0001193125-25-280136.md) | [(19.4) d](/filings/0001193125-26-104113.md) | [30.1](/filings/0001193125-26-225482.md) | [(6.6)](/filings/0001193125-26-349320.md) |
| Net income | $m | [25.5](/filings/0000950170-25-047559.md) | [2.4 d](/filings/0000950170-25-047560.md) | [40.8](/filings/0001193125-25-280136.md) | [14.0](/filings/0001193125-25-280136.md) | [(38.2)](/filings/0001193125-25-280136.md) | [75.8 d](/filings/0001193125-26-104113.md) | [22.8](/filings/0001193125-26-349320.md) | [(10.5)](/filings/0001193125-26-349320.md) | [7.2](/filings/0001193125-25-280136.md) | [(14.5) d](/filings/0001193125-26-104113.md) | [72.5](/filings/0001193125-26-349320.md) | [(18.4)](/filings/0001193125-26-349320.md) |
| Diluted EPS | $ per share | [1.42](/filings/0000950170-25-047559.md) | not reported | [2.27](/filings/0000950170-25-071619.md) | [0.78](/filings/0000950170-25-107298.md) | [(2.07)](/filings/0001193125-25-280136.md) | not reported | [1.23](/filings/0001193125-26-225482.md) | [(0.56)](/filings/0001193125-26-349320.md) | [0.39](/filings/0001193125-25-280136.md) | not reported | [3.89](/filings/0001193125-26-225482.md) | [(0.99)](/filings/0001193125-26-349320.md) |
| Basic EPS | $ per share | [1.42](/filings/0000950170-25-047559.md) | not reported | [2.27](/filings/0000950170-25-071619.md) | [0.78](/filings/0000950170-25-107298.md) | [(2.07)](/filings/0001193125-25-280136.md) | not reported | [1.23](/filings/0001193125-26-225482.md) | [(0.56)](/filings/0001193125-26-349320.md) | [0.39](/filings/0001193125-25-280136.md) | not reported | [3.89](/filings/0001193125-26-225482.md) | [(0.99)](/filings/0001193125-26-349320.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [4.4](/filings/0000950170-23-060223.md) | [10.5](/filings/0000950170-25-047560.md) | [3.0](/filings/0000950170-24-055614.md) | [2.9](/filings/0000950170-24-089245.md) | [18.1](/filings/0000950170-25-047559.md) | [14.4](/filings/0001193125-26-104113.md) | [34.9](/filings/0000950170-25-071619.md) | [38.9](/filings/0000950170-25-107298.md) | [37.7](/filings/0001193125-25-280136.md) | [36.9](/filings/0001193125-26-349320.md) | [36.7](/filings/0001193125-26-225482.md) | [34.3](/filings/0001193125-26-349320.md) |
| Current assets | $m | [6.3](/filings/0000950170-23-060223.md) | [5.0](/filings/0000950170-24-089245.md) | [4.4](/filings/0000950170-24-055614.md) | [3.9](/filings/0000950170-24-089245.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [9.3](/filings/0000950170-23-060223.md) | [1,116](/filings/0000950170-25-047560.md) | [5.7](/filings/0000950170-24-055614.md) | [5.2](/filings/0000950170-24-089245.md) | [1,624](/filings/0000950170-25-047559.md) | [2,028](/filings/0001193125-26-104113.md) | [2,073](/filings/0000950170-25-071619.md) | [2,059](/filings/0000950170-25-107298.md) | [2,183](/filings/0001193125-25-280136.md) | [1,997](/filings/0001193125-26-349320.md) | [2,234](/filings/0001193125-26-225482.md) | [1,943](/filings/0001193125-26-349320.md) |
| Current liabilities | $m | [1.2](/filings/0000950170-23-060223.md) | [0.9](/filings/0000950170-24-089245.md) | [0.7](/filings/0000950170-24-055614.md) | [0.8](/filings/0000950170-24-089245.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total liabilities | $m | [3.5](/filings/0000950170-23-060223.md) | [28.8](/filings/0000950170-25-047560.md) | [2.9](/filings/0000950170-24-055614.md) | [2.9](/filings/0000950170-24-089245.md) | [109](/filings/0000950170-25-047559.md) | [148](/filings/0001193125-26-104113.md) | [144](/filings/0000950170-25-071619.md) | [136](/filings/0000950170-25-107298.md) | [119](/filings/0001193125-25-280136.md) | [97.4](/filings/0001193125-26-349320.md) | [300](/filings/0001193125-26-225482.md) | [161](/filings/0001193125-26-349320.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [207](/filings/0000950170-25-047559.md) | [209](/filings/0001193125-26-104113.md) | [253](/filings/0001193125-25-280136.md) | [264](/filings/0001193125-25-280136.md) | [265](/filings/0001193125-25-280136.md) | [340](/filings/0001193125-26-349320.md) | [361](/filings/0001193125-26-349320.md) | [349](/filings/0001193125-26-349320.md) | [355](/filings/0001193125-25-280136.md) | [339](/filings/0001193125-26-349320.md) | [409](/filings/0001193125-26-349320.md) | [388](/filings/0001193125-26-349320.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [22.8 d](/filings/0000950170-25-047559.md) | [1.7 d](/filings/0000950170-25-047560.md) | [18.9](/filings/0000950170-25-071619.md) | [(34.3) d](/filings/0000950170-25-107298.md) | [4.2 d](/filings/0001193125-25-280136.md) | [23.0 d](/filings/0001193125-26-104113.md) | [(14.5)](/filings/0001193125-26-225482.md) | [(7.8) d](/filings/0001193125-26-349320.md) | [(17.9) d](/filings/0001193125-25-280136.md) | [(2.8) d](/filings/0001193125-26-104113.md) | [(6.8)](/filings/0001193125-26-225482.md) | [(2.0) d](/filings/0001193125-26-349320.md) |
| Capital expenditure | $m | not reported | [0.0 d](/filings/0000950170-25-047560.md) | not reported | not reported | not reported | [0.0 d](/filings/0001193125-26-104113.md) | [0.0](/filings/0001193125-26-225482.md) | [0.0 d](/filings/0001193125-26-349320.md) | not reported | not reported | [0.6](/filings/0001193125-26-225482.md) | [0.6 d](/filings/0001193125-26-349320.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | [2.0](/filings/0001193125-26-225482.md) | [1.0 d](/filings/0001193125-26-349320.md) | [1.3 d](/filings/0001193125-25-280136.md) | [2.0 d](/filings/0001193125-26-104113.md) | [2.3](/filings/0001193125-26-225482.md) | [2.4 d](/filings/0001193125-26-349320.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [12.7](/filings/0000950170-23-060223.md) | [12.8](/filings/0000950170-24-055614.md) | [12.9](/filings/0000950170-24-089245.md) | [18.0](/filings/0000950170-25-047559.md) | [18.0](/filings/0000950170-25-071619.md) | [18.0](/filings/0000950170-25-107298.md) | [18.4](/filings/0001193125-25-280136.md) | [18.6](/filings/0001193125-26-225482.md) | [18.6](/filings/0001193125-26-349320.md) | [18.6](/filings/0001193125-25-280136.md) | [18.6](/filings/0001193125-26-225482.md) | [18.6](/filings/0001193125-26-349320.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 18,635,321 at 2026-08-11, from the cover of the [10-Q filed 2026-08-13](/filings/0001193125-26-349320.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:20 ET. No prices; not investment advice.